VVN-1901

N/A

Report date: 2025/05/29 20:00:08

Base Information

Drug NameVVN-1901
Drug Alias NameVVN1901VVN-1901
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurotrophic KeratitisKeratitisCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesVivaVision Biotech Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesVivaVision Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeurotrophic KeratitisKeratitisCorneal Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A